← back to search

Christel Renoux

McGill University Health Centre · CA
Area of research
Cardiology and Cardiovascular Medicine · General Health Professions
Research interest
Research interests include Medicine, Hazard ratio, Internal medicine, Vitamin K antagonist, Type 2 diabetes, and Adverse effect.
h-index
citations
460
works
10
NIH funding
primary concept
email

Recent publications

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
BMJ 2024cited by 101position: middledoi
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis
Current Neuropharmacology 2021cited by 50position: middledoi
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression
International Journal of Cardiology 2021cited by 20position: middledoi
Non–Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury
Journal of the American College of Cardiology 2018cited by 41position: lastdoi
Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review
CNS Drugs 2018cited by 40position: lastdoi
Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation
The American Journal of Medicine 2018cited by 34position: middledoi
Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes
Epidemiology 2018cited by 17position: middledoi
Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study
BMJ 2017cited by 93position: middledoi
Patterns of long‐term use of non‐vitamin K antagonist oral anticoagulants for non‐valvular atrial fibrillation: Quebec observational study
Pharmacoepidemiology and Drug Safety 2017cited by 22position: middledoi
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
British Journal of Clinical Pharmacology 2016cited by 42position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Antonios Douros · Palo Alto Institute5 papers (2017–2018)Hui Yin · University of Birmingham4 papers (2018–2024)Samy Suissa · McGill University Health Centre4 papers (2017–2024)Laurent Azoulay · McGill University Health Centre4 papers (2018–2024)Colin R. Dormuth · McGill University Health Centre2 papers (2016–2017)Ilan Matok · Hebrew University of Jerusalem2 papers (2021–2021)Nir Treves · Hebrew University of Jerusalem2 papers (2021–2024)Hala Tamim · Dalhousie University2 papers (2016–2017)Oriana Hoi Yun Yu · Simon Fraser University2 papers (2018–2024)Pierre Ernst · Jewish General Hospital2 papers (2016–2017)Siham Gbaly · Hebrew University of Jerusalem1 papers (2021–2021)J. Michael Paterson · McGill University Health Centre1 papers (2017–2017)Russell Steele · McGill University1 papers (2016–2016)Haim Danenberg · Hadassah Medical Center1 papers (2021–2021)Benjamin Bar‐Oz · Hebrew University of Jerusalem1 papers (2021–2021)Connie Marras · University Health Network1 papers (2016–2016) · 1 papers (2016–2016)Salaheddin M. Mahmud · Cambridge University Hospitals NHS Foundation Trust1 papers (2017–2017)Tanvir Chowdhury Turin · University of Calgary1 papers (2016–2016)Sally Lu · McGill University1 papers (2024–2024)